SynthesisDiagnostic pathology2014
Glutathione S-transferase M1 null genotype meta-analysis on gastric cancer risk.
Synthesis in Diagnostic pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.
- The association of GSTM1 deletion polymorphism with lung cancer risk in Chinese population: evidence from an updated meta-analysis.Scientific reports · 2015Pooled it
- The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015Pooled it
- Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma.Diagnostic pathology · 2021Article
- Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis.Frontiers in genetics · 2020Article
- Association between polymorphisms in theOncology letters · 2019Article
- Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016Article
- Glutathione-S-Transferase Deletions and Non-arteritic Anterior Ischemic Optic Neuropathy.Molecular neurobiology · 2016Article
- The Genetic Architecture of Murine Glutathione Transferases.PloS one · 2016Article
- XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment.OncoTargets and therapy · 2016Article
- GSTM1 null genotype and gastric cancer risk in the Chinese population: an updated meta-analysis and review.OncoTargets and therapy · 2015Article
- A meta-analysis of glutathione S-transferase M1 and T1 genetic polymorphism in relation to susceptibility to nasopharyngeal carcinoma.International journal of clinical and experimental medicine · 2015Article
- Genetics and gastric cancer susceptibility.International journal of clinical and experimental medicine · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlutathione S-transferases (GSTs) have proved to be involved in the detoxifying several carcinogens and may play an important role in carcinogenesis of cancer. Previous studies on the association between Glutathione S-transferase M1 (GSTM1) polymorphism and gastric cancer (GC) risk reported inconclusive results. To get a precise result, we conducted this present meta-analysis through pooling all eligible studies.
methodsA comprehensive databases of Pubmed, Embase, Web of Science, and the Chinese Biomedical Database (CBM) were searched for case-control studies investigating the association between GSTM1 null genotype and GC risk. Odds ratios (OR) and 95% confidence intervals (95% CI) were used to assess this possible association. A χ2-based Q-test was used to examine the heterogeneity assumption. Begg's and Egger's test were used to examine the potential publication bias. The leave-one-out sensitivity analysis was conducted to determine whether our assumptions or decisions have a major effect on the results of present work. Statistical analyses were performed with the software program STATA 12.0.
resultsA total of 47 eligible case-control studies were identified, including 6,678 cases and 12,912 controls. Our analyses suggested that GSTM1 null genotype was significantly associated with increased risk of GC (OR=1.186, 95% CI=1.057-1.329, Pheterogenetiy=0.000, P=0.004). Significant association was also found in Asians (OR=1.269, 95% CI=1.106-1.455, Pheterogenetiy=0.002, P=0.001). However, GSTM1 null genotype was not contributed to GC risk in Caucasians (OR=1.115, 95% CI=0.937-1.326, Pheterogenetiy=0.000, P=0.222). In the subgroup analysis stratified by sources of controls, significant association was detected in hospital-based studies (OR=1.355, 95% CI=1.179-1.557, Pheterogenetiy=0.001, P=0.000), while there was no significant association detected in population-based studies (OR=1.017, 95% CI=0.862-1.200, Pheterogenetiy=0.000, P=0.840).
conclusionThis meta-analysis showed the evidence that GSTM1 null genotype contributed to the development of GC. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1644180505119533.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.